DaVita (NYSE:DVA) Stock Rating Lowered by Wall Street Zen

Key Points

• DaVita's stock rating was downgraded from "buy" to "hold" by Wall Street Zen, signaling a more cautious outlook from analysts.
• Several brokerages have set varying target prices for DaVita, with Truist Financial at $148.00, while Bank of America and Barclays have lowered their estimates to $140.00 and $149.00 respectively.
• DaVita reported an EPS of $2.95 for the last quarter, exceeding expectations, with a forecast for FY 2025 set between $10.200 and $11.300 EPS.

DaVita (NYSE:DVA - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Saturday.

Several other brokerages have also recently commented on DVA. Truist Financial set a $148.00 target price on shares of DaVita in a research report on Friday, August 8th. Weiss Ratings restated a "hold (c+)" rating on shares of DaVita in a research report on Wednesday. Bank of America lowered their price objective on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research report on Wednesday, September 10th. Finally, Barclays lowered their price objective on shares of DaVita from $160.00 to $149.00 and set an "equal weight" rating for the company in a research report on Thursday. Four equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Reduce" and a consensus price target of $155.25.

DaVita Stock Performance

Shares of DaVita stock opened at $123.91 on Friday. The firm has a fifty day moving average of $133.26 and a two-hundred day moving average of $139.33. The stock has a market capitalization of $8.86 billion, a price-to-earnings ratio of 12.18, a PEG ratio of 0.91 and a beta of 1.13. DaVita has a 52 week low of $123.13 and a 52 week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating the consensus estimate of $2.70 by $0.25. The company had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The business's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, research analysts forecast that DaVita will post 10.76 EPS for the current fiscal year.

Insider Transactions at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of the stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares in the company, valued at approximately $3,905,700. This represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company's stock.

Hedge Funds Weigh In On DaVita

A number of large investors have recently added to or reduced their stakes in DVA. Man Group plc increased its holdings in DaVita by 1,608.6% during the 2nd quarter. Man Group plc now owns 285,809 shares of the company's stock worth $40,713,000 after purchasing an additional 269,081 shares in the last quarter. Norges Bank bought a new position in DaVita during the 2nd quarter worth about $32,986,000. Doma Perpetual Capital Management LLC grew its holdings in shares of DaVita by 172.3% in the 1st quarter. Doma Perpetual Capital Management LLC now owns 288,360 shares of the company's stock valued at $44,110,000 after acquiring an additional 182,476 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of DaVita in the 2nd quarter valued at about $21,554,000. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of DaVita by 132.1% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 264,084 shares of the company's stock valued at $37,619,000 after acquiring an additional 150,318 shares in the last quarter. Institutional investors own 90.12% of the company's stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.